F2 and neoplasm: The primary differences between the two groups were that the patients from the lipiodol > 10 mL subgroup had larger tumor sizes (P = .001), lower pre‐interventional levels of TBIL (P = .017), and lower prothrombin time (P = .024), and higher postinterventional levels of ALT (P = .039) and AST (P = .039) than patients from the lipiodol ≤ 10 mL subgroup (Figure 2C,D).